NCT00503529View on ClinicalTrials.gov

TBE Antibody Persistence and Booster Vaccination Study in Adults (Follow-up to Study 223)

PHASE4CompletedINTERVENTIONAL
Enrollment

314

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

July 31, 2010

Study Completion Date

September 30, 2010

Conditions
Encephalitis, Tick-Borne
Interventions
BIOLOGICAL

Tick-Borne Encephalitis (TBE) Vaccine (Inactivated)

Vaccination by intramuscular injection into the right or left upper arm (musculus deltoideus)

Trial Locations (2)

33-200

Hospital in Debica - Zespol Opieki Zdrowotnej w Debicy, Dębica

31-202

Szpital Jana Pawla II (The John Paul II Hospital) Oddzial Neuroinfekcji, Krakow

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY